Promising Cancer Research Programs Need Your Help!
I am writing today to ask for your 2022 Annual Fund renewal gift to the Asian Fund for Cancer Research, and your decision is absolutely crucial! Currently, talented scientists are waiting for funding to pursue…
AFCR-Funded Innovative Immunotherapy Received Clinical Trial Approval!
Since 2020 AFCR has funded a novel multi-targeting immunotherapeutic platform that we envisioned could provide a safe and effective treatment for gastrointestinal (GI) cancers. Today I am excited to share with you the program’s recent…
AFCR Congratulates Professor Nancy Ip for Being Appointed as the President of The Hong Kong University of Science and Technology (HKUST)
The Asian Fund for Cancer Research Limited congratulates world-renowned neuroscientist, Nancy Ip, Ph.D., the Morningside Professor of Life Science and Director of the State Key Laboratory of Molecular Neuroscience at The Hong Kong University of…
Announcement: Chimera Bioengineering is the 2021 BRACE Award Venture Competition Winner
CONTACTS:Asian Fund for Cancer ResearchBradley Gillenwater, Senior Director for Corporate EngagementE-mail: bgillenwater@afcr.org Chimera BioengineeringVlad Hogenhuis, M.D., CEOE-mail: info@chimera.bio Little Dog CommunicationsJessica Yingling, Ph.D., PresidentE-mail: jessica@litldog.com / Phone: 1-858-344-8091 Asian Fund for Cancer Research Announces Chimera…
Novel Immunotherapeutic Oral Cancer Treatment
Did you know 66% of the world’s oral cancer diagnoses occur in Asia only 50% of people diagnosed will survive within 5 years the highest rates of oral cancer are found in Southeast Asia men…
